# Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors

> **NCT00075387** · PHASE2 · UNKNOWN · sponsor: **OHSU Knight Cancer Institute** · enrollment: 48 (actual)

## Conditions studied

- Malignant Glioma

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Cyclophosphamide
- **DRUG:** Etoposide Phosphate
- **OTHER:** Quality-of-Life Assessment
- **DRUG:** Sodium Thiosulfate

## Key facts

- **NCT ID:** NCT00075387
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-03-07
- **Primary completion:** 2023-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2022-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00075387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00075387, "Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00075387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*